Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Underweight on bluebird bio, Lowers Price Target to $5

Morgan Stanley maintains bluebird bio (NASDAQ:BLUE) with a Underweight and lowers the price target from $6 to $5.
byBenzinga Newsdesk
March 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley maintains bluebird bio (NASDAQ:BLUE) with a Underweight and lowers the price target from $6 to $5.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0